Lehrstuhl für Innere Medizin I (Medizin 1)


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

ST6GAL1 promotes IBD B cell recruitment to the inflamed colon in a CD22-dependent mechanism (2025) Liu L, Müller T, Dedden M, Schramm S, Leppkes M, Atreya R, Atreya I, et al. Journal article Calibration-free Laser-induced Breakdown Spectroscopy (CF-LIBS): Plasma criteria for porcine tissue (2025) Böhmer E, Degelmann LS, Thoma OM, Waldner M, Mehari F, Klämpfl F, Hohmann M, Schmidt M Journal article Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study (2025) Noviello D, Chaparro M, Viganò C, Blesl A, Barberio B, Yanai H, Orlando A, et al. Journal article Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials (2025) Linggi B, Azucena S, Steere B, Verstockt B, Alsoud D, Casero D, Mcgovern D, et al. Journal article The Thickness of the Hypoechoic Halo of Thyroid Nodules May Help to Recognize Thyroid Cancer (2025) Ji J, Shi X, Liang L Journal article CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer (2025) Xuefeng F, Yang H, Xu P, Zhang S, Britzen-Laurent N, Bao L, Grützmann R, et al. Journal article Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors (2025) Mauvais FX, Hamel Y, Silvin A, Mulder K, Hildner K, Akyol R, Dalod M, et al. Journal article Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies (2025) Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, et al. Journal article IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era? (2025) Atreya R, Neurath M Journal article, Editorial Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment (2025) Bokemeyer B, Plachta-Danielzik S, Gilman E, Di Giuseppe R, Deppe H, Mohl W, Teich N, et al. Journal article